These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18160013)

  • 21. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
    Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
    Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
    Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
    Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
    Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
    Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
    Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN
    Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.
    de Castro Cunha RM; Kallas EG; Rodrigues DS; Nascimento Burattini M; Salomao R
    Clin Exp Immunol; 2005 Jun; 140(3):491-7. PubMed ID: 15932510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
    Lekutis C; Shiver JW; Liu MA; Letvin NL
    J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient global T cell activation after vaccination of rhesus macaques with a DNA-poxvirus vaccine regimen for HIV.
    Soares A; Müller TL; Chege GK; Williamson AL; Burgers WA
    Vaccine; 2015 Jul; 33(30):3435-9. PubMed ID: 26055294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay.
    Winstone N; Guimarães-Walker A; Roberts J; Brown D; Loach V; Goonetilleke N; Hanke T; McMichael AJ
    Eur J Immunol; 2009 Apr; 39(4):975-85. PubMed ID: 19266489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination in humans generates broad T cell cytokine responses.
    De Rosa SC; Lu FX; Yu J; Perfetto SP; Falloon J; Moser S; Evans TG; Koup R; Miller CJ; Roederer M
    J Immunol; 2004 Nov; 173(9):5372-80. PubMed ID: 15494483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
    Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
    J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein.
    Tian X; Zhang Y; He Z; Li S; Yan D; Zhu Z; Wan Y; Wang W
    Front Immunol; 2022; 13():875236. PubMed ID: 35514964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles.
    Cox KS; Clair JH; Prokop MT; Sykes KJ; Dubey SA; Shiver JW; Robertson MN; Casimiro DR
    J Virol; 2008 Aug; 82(16):8161-71. PubMed ID: 18524823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection.
    Makedonas G; Betts MR
    Springer Semin Immunopathol; 2006 Nov; 28(3):209-19. PubMed ID: 16932955
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults.
    Jin X; Newman MJ; De-Rosa S; Cooper C; Thomas E; Keefer M; Fuchs J; Blattner W; Livingston BD; McKinney DM; Noonan E; Decamp A; Defawe OD; Wecker M;
    Vaccine; 2009 Nov; 27(50):7080-6. PubMed ID: 19786145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model.
    Yin J; Dai A; Laddy DJ; Yan J; Arango T; Khan AS; Lewis MG; Andersen H; Kutzler MA; Draghia-Akli R; Weiner DB; Boyer JD
    Virology; 2009 Oct; 393(1):49-55. PubMed ID: 19683780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA inducing VLP vaccine designed for HIV and tested in mice.
    Calazans A; Boggiano C; Lindsay R
    PLoS One; 2017; 12(8):e0183803. PubMed ID: 28837706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4 and CD8 cytokine-producing T cells are transiently reduced following cyclosporine intake: maximal inhibition occurs at 2 hours coincidental with drug C(max).
    Mora JR; Bono MR; Rosemblatt M; Rodriguez S; Morales J; Buckel E; Fierro A
    Transplant Proc; 2001; 33(7-8):3310-2. PubMed ID: 11750417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.